Lil­ly ven­tures in­to pul­monary fi­bro­sis with start­up Me­di­ar

Boston-area start­up Me­di­ar Ther­a­peu­tics is team­ing up with Eli Lil­ly on a new drug for id­io­path­ic pul­monary fi­bro­sis.

Lil­ly — one of the five large phar­mas …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER